海藻酸钠微球经子宫动脉栓塞治疗子宫肌瘤的疗效观察  

The curative effect of KMG in uterine artery embolism for uterine myoma

作　　者：李廉[1] 黄建邕[1] 潘少咏[1] 郑惠冰[1] 魏燮坤[1] 

机构地区：[1]广西南宁市第一人民医院,南宁530022

出　　处：《广西医学》2006年第11期1701-1703,共3页Guangxi Medical Journal

基　　金：广西南宁市科学研究与技术开发计划项目[南科(200326)]

摘　　要：目的探讨栓塞剂海藻酸钠微球（KMG）用于子宫动脉栓塞治疗子宫肌瘤的疗效。方法选择30例子宫肌瘤患者，以Seldinger技术完成单侧股动脉插管，根据数字减影血管造影（DSA）检查结果，插管至双侧子宫动脉并经DSA检查证实后，以直径为500—700／am的KMG栓塞子宫动脉。结果KMG栓塞治疗后，子宫肌瘤患者的临床症状明显缓解，月经量为原月经量的57．35％；第6、12个月肌瘤体积分别缩小59．17％、72．54％，子宫体积分别缩小45．75％、57．83％。结论KMG应用于子宫动脉栓塞治疗子宫肌瘤可有效地缩小肌瘤及子宫的体积，并明显改善子宫肌瘤患者的临床症状。Objective To study the efficacy of sodium alginate KMG, a embolismic agent used in uterine artery embolism（UAE） for treating uterine myoma.Methods UAE was performed in 30 patients with uterine myoma. Catheter was inserted into uterine arteries with the help of DSA. KMG with a diameter of 500 - 700μm was used to embohze the arteries. Results Clinical symptoms singnificantiy relieved after UAE with KMG as embolismic agent.Menorrhagia was reduced by 57.35% 6 and 12 months after UAE,the volume of uterine myoma was reduced by 59.17% and 72.54%,and the volume of uterus was reduced by 45.75% and 57.83% respectively. Conclusion KMG used in UAE can decrease the volume of myoma and utents and relieve the clinical symptoms effectively.

关 键 词：子宫肌瘤 子宫动脉栓塞 海藻酸钠微球 

分 类 号：R737.33[医药卫生—肿瘤]